Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors.
Identifieur interne : 000499 ( Main/Exploration ); précédent : 000498; suivant : 000500Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors.
Auteurs : P. Gautret [France] ; W. Yong ; G. Soula ; J. Gaudart ; J. Delmont ; A. Dia ; P. Parola ; P. BrouquiSource :
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [ 1469-0691 ] ; 2009.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Anticholestérolémiants (usage thérapeutique), Arabie saoudite (épidémiologie), Enquêtes et questionnaires (MeSH), Facteurs de risque (MeSH), Facteurs socioéconomiques (MeSH), Femelle (MeSH), France (épidémiologie), Humains (MeSH), Incidence (MeSH), Infections de l'appareil respiratoire (traitement médicamenteux), Infections de l'appareil respiratoire (épidémiologie), Jeune adulte (MeSH), Mâle (MeSH), Résultat thérapeutique (MeSH), Sujet âgé (MeSH), Voyage (MeSH), Études de cohortes (MeSH), Études prospectives (MeSH).
- MESH :
- traitement médicamenteux : Infections de l'appareil respiratoire.
- usage thérapeutique : Anticholestérolémiants.
- épidémiologie : Arabie saoudite, France, Infections de l'appareil respiratoire.
- Adulte, Adulte d'âge moyen, Enquêtes et questionnaires, Facteurs de risque, Facteurs socioéconomiques, Femelle, Humains, Incidence, Jeune adulte, Mâle, Résultat thérapeutique, Sujet âgé, Voyage, Études de cohortes, Études prospectives.
- Wicri :
- geographic : France, Arabie saoudite.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Anticholesteremic Agents (therapeutic use), Cohort Studies (MeSH), Female (MeSH), France (epidemiology), Humans (MeSH), Incidence (MeSH), Male (MeSH), Middle Aged (MeSH), Prospective Studies (MeSH), Respiratory Tract Infections (drug therapy), Respiratory Tract Infections (epidemiology), Risk Factors (MeSH), Saudi Arabia (epidemiology), Socioeconomic Factors (MeSH), Surveys and Questionnaires (MeSH), Travel (MeSH), Treatment Outcome (MeSH), Young Adult (MeSH).
- MESH :
- chemical , therapeutic use : Anticholesteremic Agents.
- geographic , epidemiology : France, Saudi Arabia.
- drug therapy : Respiratory Tract Infections.
- epidemiology : Respiratory Tract Infections.
- Adult, Aged, Cohort Studies, Female, Humans, Incidence, Male, Middle Aged, Prospective Studies, Risk Factors, Socioeconomic Factors, Surveys and Questionnaires, Travel, Treatment Outcome, Young Adult.
Abstract
A prospective epidemiological study was conducted to evaluate the incidence of febrile cough episodes among adult Muslims travelling from Marseille to Saudi Arabia during the Hajj pilgrimage and to assess if use of statin had an influence on this incidence. In total, 580 individuals were presented with a questionnaire. A significant proportion of individuals had chronic medical disorders, e.g. diabetes mellitus (132, 22.8%) and hypertension (147, 25.3%). Pilgrims had a low level of education and a low employment rate. Sixty (10.3%) were treated with statins for hypercholesterolemia. Four hundred and fourty-seven pilgrims were presented a questionnaire on returning home. A total of 74 travellers (16.6%) experienced fever during their stay in Saudi Arabia (67 attended a doctor) and 271 (60.6%) had cough (259 attended a doctor); 70 travellers with cough were febrile (25.9%). Seventy per cent of the travellers who suffered cough episodes developed their first symptoms within 3 days, suggesting a human to human transmission of the responsible pathogen, with short incubation time as evidenced by a bimodal distribution of cough in two peaks at a 24 h interval. None of demographical and socioeconomic characteristics, underlying diseases or vaccination against influenza significantly affected the occurrence of cough. Diabetes correlated with an increased risk of febrile cough (OR = 2.02 (1.05-3.89)) as well as unemployment (OR = 2.22 (0.91-5.53)). Use of statins had no significant influence on the occurrence of cough and/or fever during the pilgrimage. This result suggests that while treatment with a statin has been demonstrated to reduce the mortality from severe sepsis associated with respiratory tract infections, it probably does not play a role in the outcome of regular febrile cough episodes as observed in the cohort studied here.
DOI: 10.1111/j.1469-0691.2009.02816.x
PubMed: 19416305
PubMed Central: PMC7128324
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors.</title><author><name sortKey="Gautret, P" sort="Gautret, P" uniqKey="Gautret P" first="P" last="Gautret">P. Gautret</name><affiliation wicri:level="3"><nlm:affiliation>Service des Maladies Infectieuses et Tropicales, Hôpital Nord, AP-HM, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service des Maladies Infectieuses et Tropicales, Hôpital Nord, AP-HM, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation></author><author><name sortKey="Yong, W" sort="Yong, W" uniqKey="Yong W" first="W" last="Yong">W. Yong</name></author><author><name sortKey="Soula, G" sort="Soula, G" uniqKey="Soula G" first="G" last="Soula">G. Soula</name></author><author><name sortKey="Gaudart, J" sort="Gaudart, J" uniqKey="Gaudart J" first="J" last="Gaudart">J. Gaudart</name></author><author><name sortKey="Delmont, J" sort="Delmont, J" uniqKey="Delmont J" first="J" last="Delmont">J. Delmont</name></author><author><name sortKey="Dia, A" sort="Dia, A" uniqKey="Dia A" first="A" last="Dia">A. Dia</name></author><author><name sortKey="Parola, P" sort="Parola, P" uniqKey="Parola P" first="P" last="Parola">P. Parola</name></author><author><name sortKey="Brouqui, P" sort="Brouqui, P" uniqKey="Brouqui P" first="P" last="Brouqui">P. Brouqui</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19416305</idno><idno type="pmid">19416305</idno><idno type="doi">10.1111/j.1469-0691.2009.02816.x</idno><idno type="pmc">PMC7128324</idno><idno type="wicri:Area/Main/Corpus">000495</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000495</idno><idno type="wicri:Area/Main/Curation">000495</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000495</idno><idno type="wicri:Area/Main/Exploration">000495</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors.</title><author><name sortKey="Gautret, P" sort="Gautret, P" uniqKey="Gautret P" first="P" last="Gautret">P. Gautret</name><affiliation wicri:level="3"><nlm:affiliation>Service des Maladies Infectieuses et Tropicales, Hôpital Nord, AP-HM, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service des Maladies Infectieuses et Tropicales, Hôpital Nord, AP-HM, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation></author><author><name sortKey="Yong, W" sort="Yong, W" uniqKey="Yong W" first="W" last="Yong">W. Yong</name></author><author><name sortKey="Soula, G" sort="Soula, G" uniqKey="Soula G" first="G" last="Soula">G. Soula</name></author><author><name sortKey="Gaudart, J" sort="Gaudart, J" uniqKey="Gaudart J" first="J" last="Gaudart">J. Gaudart</name></author><author><name sortKey="Delmont, J" sort="Delmont, J" uniqKey="Delmont J" first="J" last="Delmont">J. Delmont</name></author><author><name sortKey="Dia, A" sort="Dia, A" uniqKey="Dia A" first="A" last="Dia">A. Dia</name></author><author><name sortKey="Parola, P" sort="Parola, P" uniqKey="Parola P" first="P" last="Parola">P. Parola</name></author><author><name sortKey="Brouqui, P" sort="Brouqui, P" uniqKey="Brouqui P" first="P" last="Brouqui">P. Brouqui</name></author></analytic><series><title level="j">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</title><idno type="eISSN">1469-0691</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Anticholesteremic Agents (therapeutic use)</term><term>Cohort Studies (MeSH)</term><term>Female (MeSH)</term><term>France (epidemiology)</term><term>Humans (MeSH)</term><term>Incidence (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Prospective Studies (MeSH)</term><term>Respiratory Tract Infections (drug therapy)</term><term>Respiratory Tract Infections (epidemiology)</term><term>Risk Factors (MeSH)</term><term>Saudi Arabia (epidemiology)</term><term>Socioeconomic Factors (MeSH)</term><term>Surveys and Questionnaires (MeSH)</term><term>Travel (MeSH)</term><term>Treatment Outcome (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Anticholestérolémiants (usage thérapeutique)</term><term>Arabie saoudite (épidémiologie)</term><term>Enquêtes et questionnaires (MeSH)</term><term>Facteurs de risque (MeSH)</term><term>Facteurs socioéconomiques (MeSH)</term><term>Femelle (MeSH)</term><term>France (épidémiologie)</term><term>Humains (MeSH)</term><term>Incidence (MeSH)</term><term>Infections de l'appareil respiratoire (traitement médicamenteux)</term><term>Infections de l'appareil respiratoire (épidémiologie)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Résultat thérapeutique (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Voyage (MeSH)</term><term>Études de cohortes (MeSH)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticholesteremic Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>France</term><term>Saudi Arabia</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Respiratory Tract Infections</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Respiratory Tract Infections</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections de l'appareil respiratoire</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticholestérolémiants</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Arabie saoudite</term><term>France</term><term>Infections de l'appareil respiratoire</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term><term>Risk Factors</term><term>Socioeconomic Factors</term><term>Surveys and Questionnaires</term><term>Travel</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enquêtes et questionnaires</term><term>Facteurs de risque</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Jeune adulte</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Voyage</term><term>Études de cohortes</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term><term>Arabie saoudite</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A prospective epidemiological study was conducted to evaluate the incidence of febrile cough episodes among adult Muslims travelling from Marseille to Saudi Arabia during the Hajj pilgrimage and to assess if use of statin had an influence on this incidence. In total, 580 individuals were presented with a questionnaire. A significant proportion of individuals had chronic medical disorders, e.g. diabetes mellitus (132, 22.8%) and hypertension (147, 25.3%). Pilgrims had a low level of education and a low employment rate. Sixty (10.3%) were treated with statins for hypercholesterolemia. Four hundred and fourty-seven pilgrims were presented a questionnaire on returning home. A total of 74 travellers (16.6%) experienced fever during their stay in Saudi Arabia (67 attended a doctor) and 271 (60.6%) had cough (259 attended a doctor); 70 travellers with cough were febrile (25.9%). Seventy per cent of the travellers who suffered cough episodes developed their first symptoms within 3 days, suggesting a human to human transmission of the responsible pathogen, with short incubation time as evidenced by a bimodal distribution of cough in two peaks at a 24 h interval. None of demographical and socioeconomic characteristics, underlying diseases or vaccination against influenza significantly affected the occurrence of cough. Diabetes correlated with an increased risk of febrile cough (OR = 2.02 (1.05-3.89)) as well as unemployment (OR = 2.22 (0.91-5.53)). Use of statins had no significant influence on the occurrence of cough and/or fever during the pilgrimage. This result suggests that while treatment with a statin has been demonstrated to reduce the mortality from severe sepsis associated with respiratory tract infections, it probably does not play a role in the outcome of regular febrile cough episodes as observed in the cohort studied here.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19416305</PMID><DateCompleted><Year>2009</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2009</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin. Microbiol. Infect.</ISOAbbreviation></Journal><ArticleTitle>Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors.</ArticleTitle><Pagination><MedlinePgn>335-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1469-0691.2009.02816.x</ELocationID><Abstract><AbstractText>A prospective epidemiological study was conducted to evaluate the incidence of febrile cough episodes among adult Muslims travelling from Marseille to Saudi Arabia during the Hajj pilgrimage and to assess if use of statin had an influence on this incidence. In total, 580 individuals were presented with a questionnaire. A significant proportion of individuals had chronic medical disorders, e.g. diabetes mellitus (132, 22.8%) and hypertension (147, 25.3%). Pilgrims had a low level of education and a low employment rate. Sixty (10.3%) were treated with statins for hypercholesterolemia. Four hundred and fourty-seven pilgrims were presented a questionnaire on returning home. A total of 74 travellers (16.6%) experienced fever during their stay in Saudi Arabia (67 attended a doctor) and 271 (60.6%) had cough (259 attended a doctor); 70 travellers with cough were febrile (25.9%). Seventy per cent of the travellers who suffered cough episodes developed their first symptoms within 3 days, suggesting a human to human transmission of the responsible pathogen, with short incubation time as evidenced by a bimodal distribution of cough in two peaks at a 24 h interval. None of demographical and socioeconomic characteristics, underlying diseases or vaccination against influenza significantly affected the occurrence of cough. Diabetes correlated with an increased risk of febrile cough (OR = 2.02 (1.05-3.89)) as well as unemployment (OR = 2.22 (0.91-5.53)). Use of statins had no significant influence on the occurrence of cough and/or fever during the pilgrimage. This result suggests that while treatment with a statin has been demonstrated to reduce the mortality from severe sepsis associated with respiratory tract infections, it probably does not play a role in the outcome of regular febrile cough episodes as observed in the cohort studied here.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gautret</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service des Maladies Infectieuses et Tropicales, Hôpital Nord, AP-HM, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yong</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Soula</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Gaudart</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Delmont</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Dia</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Parola</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Brouqui</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000924">Anticholesteremic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000924" MajorTopicYN="N">Anticholesteremic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014195" MajorTopicYN="N">Travel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>6</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19416305</ArticleId><ArticleId IdType="pii">S1198-743X(14)60394-3</ArticleId><ArticleId IdType="doi">10.1111/j.1469-0691.2009.02816.x</ArticleId><ArticleId IdType="pmc">PMC7128324</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Infect Dis Clin North Am. 1995 Mar;9(1):65-96</Citation><ArticleIdList><ArticleId IdType="pubmed">7769221</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2008 Jan;12(1):102-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17540601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2006 Mar 25;367(9515):1008-15</Citation><ArticleIdList><ArticleId IdType="pubmed">16564364</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacotherapy. 2007 Mar;27(3):325-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17316144</ArticleId></ArticleIdList></Reference><Reference><Citation>Trop Med Int Health. 1998 Mar;3(3):205-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9593359</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2007 Feb;35(2):372-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17205009</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2006 Dec 9;333(7580):1182-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17158361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Saudi Med. 2006 Sep-Oct;26(5):346-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17019102</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1989 Jan;129(1):125-37</Citation><ArticleIdList><ArticleId IdType="pubmed">2910056</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2008 Jun;14(6):569-74</Citation><ArticleIdList><ArticleId IdType="pubmed">18373688</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2008 Nov;121(11):1002-1007.e1</Citation><ArticleIdList><ArticleId IdType="pubmed">18954848</ArticleId></ArticleIdList></Reference><Reference><Citation>Saudi Med J. 2006 Sep;27(9):1373-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16951776</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 1998 May;36(3):303-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9661941</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2006 Jul 15;43(2):199-205</Citation><ArticleIdList><ArticleId IdType="pubmed">16779747</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2007 Apr;131(4):1006-12</Citation><ArticleIdList><ArticleId IdType="pubmed">17426203</ArticleId></ArticleIdList></Reference><Reference><Citation>J Math Psychol. 2000 Mar;44(1):41-61</Citation><ArticleIdList><ArticleId IdType="pubmed">10733857</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2007 Apr 4;297(13):1455-64</Citation><ArticleIdList><ArticleId IdType="pubmed">17405971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2006 Apr;6(4):242-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16554249</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2006 Nov;61(11):957-61</Citation><ArticleIdList><ArticleId IdType="pubmed">16809409</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2007 May;11(3):268-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16905350</ArticleId></ArticleIdList></Reference><Reference><Citation>J Travel Med. 2004 Mar-Apr;11(2):82-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15109471</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2006 Nov 11;333(7576):999</Citation><ArticleIdList><ArticleId IdType="pubmed">17060337</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2000 Jul 1;18(26):2956-62</Citation><ArticleIdList><ArticleId IdType="pubmed">10825596</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1999 Dec 16;341(25):1906-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10601511</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2007 Nov 2;82(44):384-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17972411</ArticleId></ArticleIdList></Reference><Reference><Citation>Saudi Med J. 2003 Oct;24(10):1073-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14578971</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2008 Oct 27;168(19):2081-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18955636</ArticleId></ArticleIdList></Reference><Reference><Citation>J Travel Med. 2007 Mar-Apr;14(2):132-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17367484</ArticleId></ArticleIdList></Reference><Reference><Citation>East Mediterr Health J. 2006 May-Jul;12(3-4):300-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17037698</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Oct;10(10):1882-3</Citation><ArticleIdList><ArticleId IdType="pubmed">15515248</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Provence-Alpes-Côte d'Azur</li></region><settlement><li>Marseille</li></settlement></list><tree><noCountry><name sortKey="Brouqui, P" sort="Brouqui, P" uniqKey="Brouqui P" first="P" last="Brouqui">P. Brouqui</name><name sortKey="Delmont, J" sort="Delmont, J" uniqKey="Delmont J" first="J" last="Delmont">J. Delmont</name><name sortKey="Dia, A" sort="Dia, A" uniqKey="Dia A" first="A" last="Dia">A. Dia</name><name sortKey="Gaudart, J" sort="Gaudart, J" uniqKey="Gaudart J" first="J" last="Gaudart">J. Gaudart</name><name sortKey="Parola, P" sort="Parola, P" uniqKey="Parola P" first="P" last="Parola">P. Parola</name><name sortKey="Soula, G" sort="Soula, G" uniqKey="Soula G" first="G" last="Soula">G. Soula</name><name sortKey="Yong, W" sort="Yong, W" uniqKey="Yong W" first="W" last="Yong">W. Yong</name></noCountry><country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Gautret, P" sort="Gautret, P" uniqKey="Gautret P" first="P" last="Gautret">P. Gautret</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000499 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000499 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:19416305
|texte= Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19416305" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeFranceV1
| This area was generated with Dilib version V0.6.35. |  |